Home > Boards > US Listed > Medical - Equipment > Helius Medical Technologies Inc. (HSDT)

So what are they trying to say, the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
cash_cow1 Member Profile
 
Followed By 5
Posts 846
Boards Moderated 0
Alias Born 08/30/17
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 3:31:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/3/2021 10:53:13 AM
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021 GlobeNewswire Inc. - 2/2/2021 7:30:00 AM
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-A... GlobeNewswire Inc. - 2/1/2021 5:15:00 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 1/29/2021 6:13:24 AM
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market GlobeNewswire Inc. - 1/28/2021 8:30:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/20/2021 1:15:16 PM
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medi... GlobeNewswire Inc. - 1/20/2021 7:05:00 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/20/2021 6:07:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/19/2021 7:16:01 AM
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards GlobeNewswire Inc. - 1/19/2021 7:05:00 AM
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference GlobeNewswire Inc. - 1/15/2021 12:37:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 7:16:13 AM
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS... GlobeNewswire Inc. - 1/11/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2021 4:12:40 PM
Helius Medical Technologies, Inc. Comments on Unusual Market Activity GlobeNewswire Inc. - 1/5/2021 4:05:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/5/2021 12:19:13 PM
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January GlobeNewswire Inc. - 1/4/2021 7:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/31/2020 7:21:05 AM
Helius Medical Technologies, Inc. Announces Reverse Stock Split GlobeNewswire Inc. - 12/31/2020 7:05:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 12/30/2020 6:05:42 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/21/2020 5:24:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 4:22:37 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 12/16/2020 4:19:04 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 12/10/2020 4:32:19 PM
cash_cow1   Monday, 12/30/19 01:44:10 PM
Re: tykundegex post# 154
Post # of 174 
So what are they trying to say, the patients were reaching some of these goals without the use of the PoNS neurostimulation device. The difference is that all of these patients didn't start the PoNS neurostimulation not until after 12 months after their brain injuries, then they started the program. IMO, I guess the FDA wanted half in the study to be treated with the PoNS neurostimulator device and the other half to be treated with Physical Therapy sections not using the PoNS Device. Make sense. Next complete a trial study of Patients whom have completed Physical Therapy and enroll them into the PoNS neurostimulator device Clinical study and see how well they benefited from using the PoNS device after going thru PT. What percentage of patients benefited from the PoNS Device, and what percentage of patients did not benefit from the device.

Then on the other hand I can see while Helius Medical Technologies Inc sent in their NDA for PoNS Device because they use Patients 12 months after their injuries and not before. IMO the reason why the FDA did not have enough evidence to support Helius study of the PoNS. Maybe if they would've started the study from start of traumatic injuries mild to moderate injuries, in both physical therapeutic to using the PoNS Device and a study of Patient using PT without PoNS device. Helius Medical Technologies inc would probably have an FDA Approval for the PoNS neurostimulation Device.

Please, Correct me if I'am wrong.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences